Lumanity, a company focused on bringing new therapeutics to patients, has launched today. Despite recent medical advances in drug development for complex diseases, many of these treatments sit unused as companies deal with the complexity of bringing their products to market. With over 1200 experts working in over 50 countries, Lumanity offers in-depth analysis and strategies to achieve successful market access.
According to a press release, “Lumanity is actively investing in the development of unique methods and technologies to objectively assess and demonstrate the effectiveness and value of novel therapeutics. Through its culture of pragmatic innovation and ability to apply incisive thinking, Lumanity cuts through complex situations to identify transformative approaches and drive meaningful outcomes for patients.”
Read more by clicking here.
(Source: PR Newswire, March 14th, 2022)